MeVis Medical Solutions AG (M3V.DE)
EUR 25.8
(1.57%)
EUR 25.8
(1.57%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 10.22 Million EUR | -23.53% |
| 2022 | 13.37 Million EUR | 37.78% |
| 2021 | 9.7 Million EUR | -2.58% |
| 2020 | 9.96 Million EUR | 63.53% |
| 2019 | 6.09 Million EUR | -4.19% |
| 2018 | 6.36 Million EUR | -61.61% |
| 2017 | 16.56 Million EUR | 63.81% |
| 2016 | 10.11 Million EUR | -14.43% |
| 2015 | 11.82 Million EUR | 48.05% |
| 2014 | 7.98 Million EUR | 0.71% |
| 2013 | 7.92 Million EUR | -2.68% |
| 2012 | 8.14 Million EUR | -31.08% |
| 2011 | 11.82 Million EUR | -15.55% |
| 2010 | 13.99 Million EUR | -23.72% |
| 2009 | 18.34 Million EUR | -31.98% |
| 2008 | 26.97 Million EUR | 461.24% |
| 2007 | 4.8 Million EUR | -25.49% |
| 2006 | 6.45 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.78 Million EUR | -82.51% |
| 2024 Q2 | 7.3 Million EUR | 308.31% |
| 2023 Q3 | 2.76 Million EUR | -57.8% |
| 2023 Q4 | 10.22 Million EUR | 270.18% |
| 2023 Q1 | 1.76 Million EUR | -86.78% |
| 2023 Q2 | 6.54 Million EUR | 270.36% |
| 2023 FY | 10.22 Million EUR | -23.53% |
| 2022 FY | 13.37 Million EUR | 37.78% |
| 2022 Q1 | 1.59 Million EUR | -83.61% |
| 2022 Q2 | 7.68 Million EUR | 383.21% |
| 2022 Q3 | 3 Million EUR | -60.89% |
| 2022 Q4 | 13.37 Million EUR | 344.82% |
| 2021 Q1 | 1.77 Million EUR | -82.14% |
| 2021 Q2 | 6.56 Million EUR | 268.58% |
| 2021 Q3 | 2.36 Million EUR | -63.95% |
| 2021 Q4 | 9.7 Million EUR | 310.49% |
| 2021 FY | 9.7 Million EUR | -2.58% |
| 2020 Q3 | 404.2 Thousand EUR | -94.27% |
| 2020 FY | 9.96 Million EUR | 63.53% |
| 2020 Q1 | 3.37 Million EUR | -44.56% |
| 2020 Q2 | 7.04 Million EUR | 108.68% |
| 2020 Q4 | 9.96 Million EUR | 2365.31% |
| 2019 FY | 6.09 Million EUR | -4.19% |
| 2019 Q4 | 6.09 Million EUR | 55.45% |
| 2019 Q3 | 3.92 Million EUR | 11.59% |
| 2019 Q2 | 3.51 Million EUR | -43.39% |
| 2019 Q1 | 6.2 Million EUR | -2.42% |
| 2018 Q2 | 6.98 Million EUR | -42.07% |
| 2018 Q1 | 12.05 Million EUR | -27.26% |
| 2018 FY | 6.36 Million EUR | -61.61% |
| 2018 Q3 | 6.27 Million EUR | -10.18% |
| 2018 Q4 | 6.36 Million EUR | 1.44% |
| 2017 FY | 16.56 Million EUR | 63.81% |
| 2017 Q4 | 16.56 Million EUR | 53.48% |
| 2017 Q3 | 10.79 Million EUR | -9.75% |
| 2017 Q2 | 11.96 Million EUR | 18.83% |
| 2017 Q1 | 10.06 Million EUR | 2.24% |
| 2016 Q2 | 11.83 Million EUR | 0.15% |
| 2016 Q4 | 9.84 Million EUR | 41.61% |
| 2016 FY | 10.11 Million EUR | -14.43% |
| 2016 Q1 | 11.82 Million EUR | 15.52% |
| 2016 Q3 | 6.95 Million EUR | -41.27% |
| 2015 Q1 | 7.98 Million EUR | 6.14% |
| 2015 Q3 | 9.1 Million EUR | 4.32% |
| 2015 FY | 11.82 Million EUR | 48.05% |
| 2015 Q4 | 10.23 Million EUR | 12.43% |
| 2015 Q2 | 8.72 Million EUR | 9.27% |
| 2014 Q4 | 7.52 Million EUR | 6.92% |
| 2014 FY | 7.98 Million EUR | 0.71% |
| 2014 Q3 | 7.03 Million EUR | -3.56% |
| 2014 Q2 | 7.29 Million EUR | -7.98% |
| 2014 Q1 | 7.92 Million EUR | -2.2% |
| 2013 Q3 | 8.15 Million EUR | 0.51% |
| 2013 Q4 | 8.1 Million EUR | -0.55% |
| 2013 FY | 7.92 Million EUR | -2.68% |
| 2013 Q1 | 8.14 Million EUR | -35.75% |
| 2013 Q2 | 8.11 Million EUR | -0.44% |
| 2012 Q1 | 11.82 Million EUR | -19.93% |
| 2012 Q3 | 11.91 Million EUR | 0.13% |
| 2012 Q4 | 12.67 Million EUR | 6.4% |
| 2012 FY | 8.14 Million EUR | -31.08% |
| 2012 Q2 | 11.9 Million EUR | 0.68% |
| 2011 FY | 11.82 Million EUR | -15.55% |
| 2011 Q2 | 14.07 Million EUR | 0.53% |
| 2011 Q1 | 13.99 Million EUR | -23.04% |
| 2011 Q3 | 14.11 Million EUR | 0.34% |
| 2011 Q4 | 14.76 Million EUR | 4.56% |
| 2010 Q2 | 18.29 Million EUR | -0.29% |
| 2010 FY | 13.99 Million EUR | -23.72% |
| 2010 Q1 | 18.34 Million EUR | 0.0% |
| 2010 Q4 | 18.18 Million EUR | -0.73% |
| 2010 Q3 | 18.31 Million EUR | 0.14% |
| 2009 FY | 18.34 Million EUR | -31.98% |
| 2009 Q3 | 23.81 Million EUR | 0.0% |
| 2008 FY | 26.97 Million EUR | 461.24% |
| 2007 FY | 4.8 Million EUR | -25.49% |
| 2006 FY | 6.45 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| DocCheck AG | 21.07 Million EUR | 51.467% |
| CompuGroup Medical SE & Co. KGaA | 1.23 Billion EUR | 99.169% |
| Nexus AG | 153.13 Million EUR | 93.321% |